Skip to main content

Christine Lovly Archives

Christine Lovly 2021 recipient of the ECOG-ACRIN Young Investigator Award

Jun. 9, 2021—Christine Lovly, MD, PhD, is the recipient of the 2021 ECOG-ACRIN Young Investigator Award, a major recognition of research excellence.

Read more


Vanderbilt researchers present new data on clinical trials at ASCO 2021

May. 26, 2021—Vanderbilt-Ingram Cancer Center researchers will present data on clinical trials involving targeted therapies, immunotherapies and drug combination synergies at the 2021 American Society of Clinical Oncology Annual Meeting, June 4-8. The meeting is a virtual event this year.

Read more


Personalized Structural Biology aids cancer treatment decisions

Apr. 8, 2021—Cancer specialists at Vanderbilt University Medical Center, in partnership with biochemists and structural biologists across the Vanderbilt University campus, are taking “personalized” cancer therapy to a new level.

Read more


EGFR Resisters/LUNGevity fund lung cancer research

Mar. 18, 2021—Christine Lovly, MD, PhD, associate professor of Medicine in the Division of Hematology and Oncology and Ingram Professor of Cancer Research, is one of two inaugural recipients of the EGFR Resisters/LUNGevity Lung Cancer Research Award.

Read more


Gift in memory of Phran Galante boosts lung cancer research

Feb. 25, 2021—A gift in memory of music industry executive and community philanthropist Phran Galante will support the work of Christine Lovly, MD, PhD, associate professor of Medicine and Ingram Professor of Cancer Research, to improve targeted therapies for lung cancer.

Read more


Lovly to chair foundation’s scientific leadership board

Oct. 29, 2020—Christine Lovly, MD, PhD, Ingram Associate Professor of Cancer Research, has been named incoming chair of GO2 Foundation's Scientific Leadership Board (SLB).

Read more


Diversity role model inspires career path

Oct. 1, 2020—Portia Thomas grew up in Doerun, Georgia, a small, rural city named by pioneer hunters as a place with “a perfect doe run,” where the population has hovered around 800 people for the past 30 years. A childhood impression lifted her aspirations beyond her hometown and inspired her to pursue a career as a physician-scientist.

Read more


Early-career investigators

Mar. 12, 2020—Henry Henderson, PhD, was one of 16 researchers selected to participate in the American Association for Cancer Research’s Early-Career Investigator Hill Day on Feb. 27 in Washington, D.C. While there, he met with U.S. Sen. Marsha Blackburn and discussed funding for the National Institutes of Health and the National Cancer Institute with a member of the senator’s health policy staff.

Read more


Advocacy group’s gift boosts lung cancer research efforts

Feb. 13, 2020—An advocacy group for patients with anaplastic lymphoma kinase positive lung cancer has awarded a $500,000 grant dedicated to overcoming treatment resistance to the cancer.

Read more


Study reframes approach to targeted therapy resistance

Apr. 11, 2019—When a tumor mutates and develops resistance to a targeted therapy, researchers often focus on the acquisition of new mutations within the drug target as they seek an alternative treatment, but a team of Vanderbilt scientists has shown this may not be sufficient.

Read more


Investigators map genomic landscape of very rare cancer

Feb. 28, 2019—A team of Vanderbilt researchers mapped out the genomic landscape of a metastatic malignant proliferating tricholemmal tumor and identified a targeted treatment for this very rare cancer.

Read more


VUMC celebrates personalized care successes, charts course for FY19

Aug. 2, 2018—During the August Leadership Assembly at Vanderbilt University Medical Center, patients whose lives have been restored through personalized care shared their emotional stories, illustrating the Medical Center’s longtime commitment to use the latest advancements in genomic medicine as a powerful tool to tailor care to the individual.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more